WHI hormone trials offer reassurance on long-term mortality riskSeptember 12, 2017MenopauseGynecology
Study finds low risk for jaw osteonecrosis with denosumab for postmenopausal osteoporosisSeptember 9, 2017OsteoporosisMenopause
Focus on lifestyle to manage menopause symptoms after breast cancerAugust 30, 2017MenopauseBreast Cancer
Romosozumab cuts new vertebral fracture risk by 73%, but safety data are concerningJune 15, 2017OsteoporosisMenopausePreventive Care
Endometrial cancer rates increased following WHIMay 9, 2017Gynecologic CancerGynecologyMenopausePreventive Care
Updated osteoporosis guideline advocates bisphosphonates, nixes estrogensMay 8, 2017MenopauseOsteoporosis
Postmenopausal hot flashes cut by 93% with novel nonhormonal treatmentApril 26, 2017MenopauseGynecology
Study shows no adverse events with long-term denosumab in postmenopausal womenApril 14, 2017OsteoporosisMenopause
